|
TRIM26 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.52880041959236E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.5803199999942E-05 |
| Normal-vs-Stage2 |
7.6000000000076E-05 |
| Normal-vs-Stage3 |
2.12859999626502E-08 |
| Normal-vs-Stage4 |
7.44210004732793E-09 |
| Stage1-vs-Stage2 |
6.128000E-02 |
| Stage1-vs-Stage3 |
1.224360E-02 |
| Stage1-vs-Stage4 |
3.757700E-03 |
| Stage2-vs-Stage3 |
9.829800E-01 |
| Stage2-vs-Stage4 |
6.492200E-01 |
| Stage3-vs-Stage4 |
6.024200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.33870026175487E-10 |
| Normal-vs-AfricanAmerican |
4.241200E-04 |
| Normal-vs-Asian |
8.112000E-01 |
| Caucasian-vs-AfricanAmerican |
8.556400E-01 |
| Caucasian-vs-Asian |
1.810220E-01 |
| AfricanAmerican-vs-Asian |
2.190600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.9782400424192E-13 |
| Normal-vs-Female |
8.569300E-04 |
| Male-vs-Female |
1.045450E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.64819999999888E-05 |
| Normal-vs-Age(41-60Yrs) |
8.32209999801492E-08 |
| Normal-vs-Age(61-80Yrs) |
3.82070042270755E-10 |
| Normal-vs-Age(81-100Yrs) |
3.833400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.128000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.231400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.999030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.071600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.137200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.559800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.860200E-01 |
| Normal-vs-Grade 2 |
4.22579999992401E-07 |
| Normal-vs-Grade 3 |
1.43379999983928E-07 |
| Normal-vs-Grade 4 |
2.68539634973308E-11 |
| Grade 1-vs-Grade 2 |
1.890200E-01 |
| Grade 1-vs-Grade 3 |
1.667380E-01 |
| Grade 1-vs-Grade 4 |
4.420500E-03 |
| Grade 2-vs-Grade 3 |
5.162600E-01 |
| Grade 2-vs-Grade 4 |
1.443130E-03 |
| Grade 3-vs-Grade 4 |
8.364100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.341400E-03 |
| Normal-vs-ccB subtype |
1.63302704692114E-12 |
| ccA subtype-vs-ccB subtype |
4.92020000297799E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.46920000002149E-08 |
| Normal-vs-N1 |
1.413870E-02 |
| N0-vs-N1 |
5.787000E-01 |
|
|
